Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 10Recruiting 4Active not recruiting 2Withdrawn 1Unknown 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 298Neoplasms 179Breast Neoplasms 169Colorectal Neoplasms 107Neoplasm Metastasis 99Melanoma 99Multiple Myeloma 93Prostatic Neoplasms 90Ovarian Neoplasms 83Recurrence 79Carcinoma, Renal Cell 73Lung Neoplasms 71Stomach Neoplasms 67Squamous Cell Carcinoma of Head and Neck 66Lymphoma, Non-Hodgkin 61Pancreatic Neoplasms 59Leukemia, Lymphocytic, Chronic, B-Cell 56Leukemia, Myeloid, Acute 54Carcinoma, Hepatocellular 48Triple Negative Breast Neoplasms 46Urinary Bladder Neoplasms 45Small Cell Lung Carcinoma 45Lymphoma, Large B-Cell, Diffuse 43Head and Neck Neoplasms 41Endometrial Neoplasms 41Lymphoma, Follicular 39Lymphoma 37Uterine Cervical Neoplasms 35Parkinson Disease 4, Autosomal Dominant Lewy Body 34Glioblastoma 34

Interventions

relugolix 1Robotic Surgical Procedures 1Norethindrone Acetate 1Hysterectomy 1Estradiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × INDUSTRY × Endometriosis × Clear all
NCT07120945 2026-06-02

Embrace Gyn

Medtronic - MITG

Phase NA Active not recruiting
70 enrolled
GynecologicOther neoplasm

Uterine Cervical Neoplasms, Endometriosis, Leiomyoma, Menstruation Disturbances, Ovarian Neoplasms, Precancerous Conditions, Uterine Prolapse, Endometrial Neoplasms, Adenomyosis

NCT05739136 2025-08-01

MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy

Sumitomo Pharma Switzerland GmbH

Active not recruiting
530 enrolled

Endometriosis, Leiomyoma, Pregnancy Complications

Data powered by HemOnc (CC BY 4.0) Colophon ⚡